시장보고서
상품코드
1878987

통증 한랭요법 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 제품별, 용도별, 유통 채널별, 지역별 세분화 및 경쟁 구도(2020-2030년)

Cold Pain Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Product, By Application, By Distribution Channel, By Region and Competition, 2020-2030F

발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 181 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 통증 한랭요법 시장은 2024년에 22억 8,000만 달러로 평가되었고, 2030년까지 연평균 복합 성장률(CAGR) 5.72%로 성장하여 31억 8,000만 달러에 이를 것으로 예측됩니다.

통증 한랭요법은 국소적으로 냉기를 쬐어 통증을 완화하고 염증을 억제하며 부종을 최소화하는 치료법입니다. 주요 시장 성장 촉진요인으로는 전 세계적으로 고령 인구 증가로 인한 근골격계 질환의 유병률 증가, 스포츠 부상 및 외상 사고 발생률 증가를 들 수 있습니다. 또한, 오피오이드 계열 약물을 대체할 수 있는 비약물적, 비침습적 통증 관리 솔루션에 대한 환자들의 선호도가 높아지면서 시장 성장에 크게 기여하고 있습니다.

시장 개요
예측 기간 2026-2030년
시장 규모 : 2024년 22억 8,000만 달러
시장 규모 : 2030년 31억 8,000만 달러
CAGR : 2025-2030년 5.72%
성장 속도가 가장 빠른 부문 OTC 제품
최대 시장 북미

주요 시장 성장 촉진요인

주요 시장 과제

주요 시장 동향

자주 묻는 질문

  • 세계의 통증 한랭요법 시장 규모는 어떻게 되며, 향후 성장률은 어떻게 예측되나요?
  • 통증 한랭요법의 주요 성장 촉진 요인은 무엇인가요?
  • 통증 한랭요법 시장에서 가장 빠르게 성장하는 부문은 무엇인가요?
  • 통증 한랭요법 시장의 최대 시장은 어디인가요?
  • 통증 한랭요법 시장의 주요 과제는 무엇인가요?
  • 통증 한랭요법 시장의 주요 동향은 무엇인가요?

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 통증 한랭요법 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품별(일반 의약품, 처방전 의약품)
    • 용도별(근골격계 질환, 수술후 요법, 스포츠 부상, 기타)
    • 유통 채널별(소매 약국, 병원 약국, 온라인 약국)
    • 지역별
    • 기업별(2024년)
  • 시장 맵

제6장 북미의 통증 한랭요법 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 북미 : 국가별 분석
    • 미국
    • 캐나다
    • 멕시코

제7장 유럽의 통증 한랭요법 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 유럽 : 국가별 분석
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 스페인

제8장 아시아태평양의 통증 한랭요법 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 아시아태평양 : 국가별 분석
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주

제9장 중동 및 아프리카의 통증 한랭요법 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 중동 및 아프리카 : 국가별 분석
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 남아프리카공화국

제10장 남미의 통증 한랭요법 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 남미 : 국가별 분석
    • 브라질
    • 콜롬비아
    • 아르헨티나

제11장 시장 역학

  • 성장 촉진요인
  • 과제

제12장 시장 동향과 발전

  • 인수합병(M&A)
  • 제품 출시
  • 최근 동향

제13장 세계의 통증 한랭요법 시장 : SWOT 분석

제14장 Porter의 Five Forces 분석

  • 업계내 경쟁
  • 신규 참여 가능성
  • 공급업체의 힘
  • 고객의 힘
  • 대체품의 위협

제15장 경쟁 구도

  • Hisamitsu Pharmaceutical CO., Inc
  • 3M Company
  • Johnson & Johnson Service Inc.
  • Pfizer Inc.
  • DeRoyal Industries, Inc.
  • Sanofi SA
  • Beiersdorf AG
  • Ossur hf.
  • Cardinal Health Inc.

제16장 전략적 제안

제17장 회사 소개 및 면책조항

LSH 25.12.11

The Global Cold Pain Therapy Market, valued at USD 2.28 Billion in 2024, is projected to experience a CAGR of 5.72% to reach USD 3.18 Billion by 2030. Cold pain therapy, also known as cryotherapy, involves the localized application of cold to alleviate pain, reduce inflammation, and minimize swelling. Key market drivers include the rising global geriatric population, which increases the prevalence of age-related musculoskeletal conditions, alongside a growing incidence of sports injuries and traumatic accidents. Furthermore, escalating patient preference for non-pharmacological, non-invasive pain management solutions over opioid-based alternatives significantly supports market growth.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.28 Billion
Market Size 2030USD 3.18 Billion
CAGR 2025-20305.72%
Fastest Growing SegmentOTC Products
Largest MarketNorth America

Key Market Drivers

The increasing prevalence of musculoskeletal disorders significantly drives the global cold pain therapy market. Conditions such as chronic back pain and osteoarthritis frequently necessitate effective pain and inflammation management. According to the Centers for Disease Control and Prevention NCHS Data Brief, in October 2024, 24.3% of U. S. adults reported experiencing chronic pain in 2023, a substantial portion of which benefits from non-pharmacological cold therapy interventions. Concurrently, the rising incidence of sports and traumatic injuries acts as another critical market accelerant. Individuals facing accidental trauma or sports-related injuries often require immediate and ongoing cold therapy for swelling reduction, pain alleviation, and accelerated recovery.

Key Market Challenges

A primary challenge impeding the expansion of the Global Cold Pain Therapy Market is the pervasive availability and widespread use of low-cost alternative pain relief options, specifically oral analgesic pills. Consumers often favor oral analgesics due to their convenience, immediate accessibility in diverse retail environments, and significantly lower unit cost compared to cold therapy devices or recurring cold pack purchases. This ingrained preference for familiar, inexpensive pharmaceutical solutions for various types of pain creates a formidable barrier to the broader adoption of cold therapy.

This strong consumer reliance on readily available and economical oral medications directly hinders market penetration for cold pain therapy. While cold therapy offers distinct non-pharmacological benefits, the established habit of choosing pills for quick symptomatic relief presents a substantial competitive disadvantage. According to the Consumer Healthcare Products Association, in 2023, retail sales of all over-the-counter medicines in the US reached $43.4 billion, demonstrating the considerable scale and entrenched consumer dependency on these accessible pharmaceutical alternatives. This vast and cost-effective market for oral analgesics limits growth opportunities and shifts potential customers away from cold pain therapy solutions.

Key Market Trends

The integration of smart technology significantly enhances cold pain therapy through improved functionality and personalized treatment. Devices now feature app connectivity, remote monitoring, and intelligent controls for precise temperature regulation. This supports real-time progress tracking and better recovery management. According to the U. S. Department of Health and Human Services, IoT-enabled healthcare devices increased by 45% between 2021 and 2023, showcasing a broad industry shift towards connected health. At CES 2024, Infuzamed introduced a wearable infusion pump with advanced remote monitoring, demonstrating potential for similar integration in cold therapy for continuous, personalized care.

Key Market Players

  • Hisamitsu Pharmaceutical CO., Inc
  • 3M Company
  • Johnson & Johnson Service Inc.
  • Pfizer Inc.
  • DeRoyal Industries, Inc.
  • Sanofi SA
  • Beiersdorf AG
  • Ossur hf.
  • Cardinal Health Inc.

Report Scope:

In this report, the Global Cold Pain Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cold Pain Therapy Market, By Product:

  • OTC Products
  • Prescription Products

Cold Pain Therapy Market, By Application:

  • Musculoskeletal Disorders
  • Post-Operative Therapy
  • Sport Injuries
  • Others

Cold Pain Therapy Market, By Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

Cold Pain Therapy Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Cold Pain Therapy Market.

Available Customizations:

Global Cold Pain Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cold Pain Therapy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (OTC Products, Prescription Products)
    • 5.2.2. By Application (Musculoskeletal Disorders, Post-Operative Therapy, Sport Injuries, Others)
    • 5.2.3. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Cold Pain Therapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cold Pain Therapy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Distribution Channel
    • 6.3.2. Canada Cold Pain Therapy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Distribution Channel
    • 6.3.3. Mexico Cold Pain Therapy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Distribution Channel

7. Europe Cold Pain Therapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cold Pain Therapy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. France Cold Pain Therapy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. United Kingdom Cold Pain Therapy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. Italy Cold Pain Therapy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. Spain Cold Pain Therapy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Cold Pain Therapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cold Pain Therapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. India Cold Pain Therapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. Japan Cold Pain Therapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. South Korea Cold Pain Therapy Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Australia Cold Pain Therapy Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Cold Pain Therapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Cold Pain Therapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. UAE Cold Pain Therapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. South Africa Cold Pain Therapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Distribution Channel

10. South America Cold Pain Therapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cold Pain Therapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Colombia Cold Pain Therapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. Argentina Cold Pain Therapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Cold Pain Therapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Hisamitsu Pharmaceutical CO., Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. 3M Company
  • 15.3. Johnson & Johnson Service Inc.
  • 15.4. Pfizer Inc.
  • 15.5. DeRoyal Industries, Inc.
  • 15.6. Sanofi SA
  • 15.7. Beiersdorf AG
  • 15.8. Ossur hf.
  • 15.9. Cardinal Health Inc.

16. Strategic Recommendations

17. About Us & Disclaimer

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제